Ormat Technologies Inc.

Published : September 30th, 2015

Herman Miller, AeroVironment, Medicines Company, Ormat Technologies and Prothena highlighted as Zacks Bull and Bear of the Day

( 0 vote, 0/5 ) Print article
  Article Comments Comment this article Rating Follow Company  
0
Send
0
comment

Herman Miller, AeroVironment, Medicines Company, Ormat Technologies and Prothena highlighted as Zacks Bull and Bear of the Day

Chicago, IL – September 30, 2015– Zacks Equity Research highlights Herman Miller ( MLHR )as the Bull of the Day and AeroVironment ( AVAV ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Medicines Company ( MDCO ), Ormat Technologies Inc. ( ORA) and Prothena Corporation plc ( PRTA ).

Here is a synopsis of all five stocks:

Bull of the Day:

Earnings estimates have been rising for Herman Miller ( MLHR ) after the company delivered strong fiscal 2016 first quarter results. Not only did sales and earnings beat expectations, management provided Q2 EPS guidance above consensus. It is a Zacks Rank #1 (Strong Buy) stock.

The valuation picture looks very reasonable too with shares trading at just 13x 12-month forward earnings.

Herman Miller designs and manufactures interior furnishings such as seating, freestanding furniture, storage, casegood and textile products, which are used in various environments including office, healthcare, educational, and residential settings. The company also acquired Design Within Reach in July 2014.

Strong First Quarter Results

Herman Miller delivered strong fiscal 2016 first quarter results on September 16. Earnings per share came in at $0.56, beating the Zacks Consensus Estimate of $0.47. It was a 19% increase over the same quarter last year.

Net sales rose 11% to $565.4 million, also ahead of the consensus of $555.0 billion. Excluding acquisitions and foreign currency translation, sales increased 8% year-over-year.

Its North American Furniture Solutions segment, which accounted for approximately 60% of net sales, delivered organic sales growth of 7%.

The company also delivered meaningful profit margin expansion. Gross profit as a percentage of net sales expanded 190 basis points to 38.3%. And its operating margin expanded to its highest level in more than six years at 9.7%.

Bear of the Day :

Earnings estimates have fallen sharply for AeroVironment ( AVAV ) after the company delivered disappointing first quarter results on September 1. The drop in consensus estimates was large enough to send the stock to a Zacks Rank #5 (Strong Sell), placing it in the bottom 5% of all stocks that Zacks ranks.

While shares are trading near their 52-week lows, the stock does not look cheap at 120x forward earnings.

AeroVironment designs and manufactures Unmanned Aircraft Systems (i.e. drones) for military, public safety and commercial activities around the world. It also develops Efficient Energy Systems for electric transportation solutions.

Approximately 85% of sales come from its Unmanned Aircraft Systems segment with the remainder coming from its Efficient Energy Solutions segment.

First Quarter Results

AeroVironment reported disappointing first quarter results on September 1. Adjusted earnings per share came in at -$0.24, below the Zacks Consensus Estimate of -$0.18. The company also burnt through more than $11 million in operating cash flow in the quarter.

Total revenue fell 9% to $47.1 million, missing the consensus of $56.0 million. Revenue declined in both segments. Unmanned Aircraft Systems saw a 2% decline in revenue while revenue in its Efficient Energy Systems segment fell 36%.

Despite the drop in revenue, selling, general and administrative expenses climbed 14%. And research and development costs jumped 38%. These factors led to a 40% plunge in operating income to -$9.1 million.

Estimates Falling

Following disappointing first quarter results, analysts revised their earnings estimates significantly lower for the remainder of the year. This was sharp enough to send the stock to a Zacks Rank #5 (Strong Sell), placing it in the bottom 5% of all stocks that Zacks ranks based on earnings momentum.

Additional content:

3 Stocks Have Gained Over 25% -- Time to Book Profits?

The fall of the bull market in the U.S. came too fast with the economic activities currently expanding at a moderate pace. The year-to-date decline of nearly 9% in the S&P 500 index has given investors no reason to cheer so far in this year.


While extreme volatility of the market has led to valuation corrections of certain stocks -- providing a golden opportunity to buy them, the irrational movements and exuberance related to the anticipated rate hike have unduly escalated certain asset values.


The elevated prices may seem attractive to investors in the dull local market, which remains highly impacted by the global weakness.


However, the prices of such stocks have deviated from their intrinsic valuation levels, which tend to correct themselves quickly, raising doubts about a company's value and strategic direction in the long run. While making tactical decisions regarding their portfolios, investors need to understand the reasons for such short-term prices changes and stick to their long-term strategic plans.


One way of doing this is to select and add stocks with strong fundamentals and steady dividend income. However, the other alternative is equally effective, which is to book profits on the overpriced stocks with no potential for future growth.


3 Stocks to Book Profits


Selecting stocks to dump could be a tricky proposition. However, with the assistance of our Zacks Stock Screener, one can locate stocks with a red flag.


Here we have zeroed in on three stocks that have gained more than 25% year-to-date despite weak fundamentals. The catch is, however, that these stocks are either a Zacks Rank #4 (Sell) or #5 (Strong Sell) with a negative projected EPS growth rate (F1/F0), thus sounding an early warning of danger ahead.


New Jersey-based The Medicines Company ( MDCO ) acquires, develops and commercializes biopharmaceutical products in late stages of development. The U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment of patients with unstable angina undergoing coronary balloon angioplasty.


Though the company’s shares have gained over 38% year-to-date, the disappointing outlook for the second-half of 2015 signals a reversal in the price chart soon enough. Moreover, generic competition for Angiomax, pipeline setbacks as well as slow Cleviprex sales justify its Zacks Rank #5 and projected EPS growth rate of -482% as against the industry average of 4.9%.


Headquartered in Nevada, Ormat Technologies Inc. ( ORA) is a provider of alternative and renewable energy technology. The company engages in the geothermal and recovered energy power business worldwide and operates in two segments, Electricity and Product.


Despite over 25% year-to-date rise in share prices, the material impact on the company’s Electricity segment owing to oil and natural gas prices continue to be a major concern. Though the company’s latest results showed better cost control, pressurized revenues and compressed margin substantiates its Zacks Rank #4 and projected EPS growth rate of -3.0%, compared with the industry average of 28.5%.


The Ireland-based Prothena Corporation plc ( PRTA ) is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and Metastatic Cancer and Tau for Alzheimer's disease.


This Zacks Rank #4 company witnessed a more than twofold increase in its ADRs on a year-to-date basis despite reporting loss in the first-half of 2015. Being a development-stage biotechnology company, it does not have any approved product in its portfolio yet. Hence, the company’s top line mainly comprises collaboration revenues including reimbursements under its license agreement with Roche.


Moreover, higher research and development expenses as a result of elevated spending for pipeline development as well as personnel costs further weighs on the future growth prospects of the company. The company’s projected EPS growth rate stands at -786.2% as against the industry average of 4.9%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today. Find out What is happening in the stock market today on zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HERMAN MILLER (MLHR): Free Stock Analysis Report
 
AEROVIRONMENT (AVAV): Free Stock Analysis Report
 
MEDICINES CO (MDCO): Free Stock Analysis Report
 
ORMAT TECH INC (ORA): Free Stock Analysis Report
 
PROTHENA CP PLC (PRTA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Read the rest of the article at finance.yahoo.com
Data and Statistics for these countries : Ireland | Jersey | All
Gold and Silver Prices for these countries : Ireland | Jersey | All

Ormat Technologies Inc.

CODE : ORA
ISIN : US6866881021
Follow and Invest
Add to watch list Add to your portfolio Add or edit a note
Add Alert Add to Watchlists Add to Portfolio Add Note
ProfileMarket
Indicators
VALUE :
Projects & res.
Press
releases
Annual
report
RISK :
Asset profile
Contact Cpy

Ormat technologies is based in United states of america.

Ormat technologies holds various exploration projects in Indonesia and in USA.

Its main exploration properties are HEBER in USA and SARULLA in Indonesia.

Ormat technologies is listed in Germany and in United States of America. Its market capitalisation is US$ 4.5 billions as of today (€ 3.9 billions).

Its stock quote reached its highest recent level on February 26, 2021 at US$ 98.73, and its lowest recent point on December 08, 2022 at US$ 88.45.

Ormat technologies has 50 597 124 shares outstanding.

Your feedback is appreciated, please leave a comment or rate this article.
Rate : Average note :0 (0 vote) View Top rated
 
Annual reports of Ormat Technologies Inc.
2008 Annual Report
Financings of Ormat Technologies Inc.
5/19/2016Ormat Technologies Secures $36 Million Supply & EPC Contract...
5/23/2014(Sarulla)Sarulla Consortium Reached Financial Closing Under the $1.17...
Financials of Ormat Technologies Inc.
5/25/2016Document: Insider Ownership
5/4/2016Ormat Technologies Reports First Quarter Revenue of $151.6 M...
11/4/2015Ormat Technologies Reports 2015 Third Quarter Results
8/3/2015Ormat Technologies Reports 2015 Second Quarter Results
2/26/2014Reports 2013 Fourth Quarter and Year End Results
11/5/2013Reports 2013 Third Quarter Results
8/7/2013Reports 2013 Second Quarter Results
Project news of Ormat Technologies Inc.
7/27/2017Document: Ownership Filing
7/5/2016Document: Insider Ownership
Corporate news of Ormat Technologies Inc.
8/10/2016Document: Insider Ownership
8/3/2016Ormat Technologies beats 2Q profit forecasts
8/2/20165:05 pm Ormat Tech beats by $0.07, beats on revs; reaffirms ...
4/18/2016SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEME...
1/21/2016Ormat Technologies, Inc. to Host Conference Call Announcing ...
12/10/2015Ormat Technologies, Inc. (ORA): Are Hedge Funds Right About ...
11/4/2015Edited Transcript of ORA earnings conference call or present...
11/4/2015Ormat Technologies meets 3Q profit forecasts
11/3/20155:56 pm Ormat Tech misses by $0.03, beats on revs; guides FY...
11/3/2015Ms. Dita Bronicki Retiring From Board of Directors
11/3/2015Ormat Technologies Reports 2015 Third Quarter Results
10/15/2015Ormat Technologies, Inc. to Host Conference Call Announcing ...
10/15/2015Ormat and Toshiba Sign Strategic Collaboration Agreement
9/30/2015Herman Miller, AeroVironment, Medicines Company, Ormat Techn...
9/29/2015Carl Icahn Predicts 'Bloodbath': Time to Book Profits?
8/8/201510-Q for Ormat Technologies, Inc.
8/4/2015Edited Transcript of ORA earnings conference call or present...
7/24/2015Weakness Seen in Covanta Holding (CVA): Stock Fall 6% - Tale...
7/16/2015Ormat Technologies, Inc. to Host Conference Call Announcing ...
5/10/201510-Q for Ormat Technologies, Inc.
4/22/20153 Green Stocks for Earth Day - Analyst Blog
4/15/2015Ormat Technologies, Inc. to Host Conference Call Announcing ...
4/15/2015Ormat Signs Power Purchase Agreement for Second Phase of Don...
4/15/2015Ormat Announces Investor & Analyst Day March 31, 2015 in New...
3/19/2015Les nouvelles bonnes pratiques du M3AAWG pour les fournisseu...
3/17/2015New M3AAWG Hosting Service Providers Best Practices Backed b...
3/11/2015La mise à jour du document de bonnes pratiques du M3AAWG à d...
3/11/2015La mise à jour du document de bonnes pratiques du M3AAWG à d...
3/11/2015La mise à jour du document de bonnes pratiques du M3AAWG à d...
3/11/2015La mise à jour du document de bonnes pratiques du M3AAWG à d...
3/11/2015La mise à jour du document de bonnes pratiques du M3AAWG à d...
3/10/2015Updated M3AAWG Best Practices for Senders Urge Opt-In Only M...
2/25/2015Ormat Technologies posts 4Q profit
2/25/2015Ormat Technologies Reports 2014 Fourth Quarter and Year End ...
2/5/2015Ormat Technologies Inc. Announces $175 Million Agreement Wit...
2/2/2015Ormat Technologies, Inc. to Host Conference Call Announcing ...
11/6/2014Ormat Technologies posts 3Q profit
11/26/2013Completes Final Drawdown of $45 Million From OPIC for Final ...
7/12/2011ALERT: New Ormat Technologies Inc event
2/12/2009Commissions the First Two Facilities of the OREG 2 Project
8/6/2007to Supply Recovered Energy Generation Unit to the Italcement...
Comments closed
 
Latest comment posted for this article
Be the first to comment
Add your comment
NYSE (ORA)FRANKFURT (HNM.F)
88.45-1.16%0.000-100.00%
NYSE
US$ 88.45
12/08 16:00 -1.04
-1.16%
Prev close Open
89.49 89.80
Low High
88.14 90.30
Year l/h YTD var.
62.92 -  100.93 11.54%
52 week l/h 52 week var.
62.92 -  100.93 11.45%
Volume 1 month var.
249,748 -11.63%
24hGold TrendPower© : 24
Produces
Develops
Explores for
 
 
 
Analyse
Interactive chart Add to compare
Interactive
chart
Print Compare Export
You must be logged in to use the porfolio and watchlists (free)
Top Newsreleases
MOST READ
Annual variation
DateVariationHighLow
202211.54%98.4760.32
2021-12.16%98.73102.56
202021.16%91.9953.44
201942.63%79.1850.41
2018-18.32%70.6845.79
 
5 years chart
 
3 months chart
 
3 months volume chart
 
 
Mining Company News
Plymouth Minerals LTDPLH.AX
Plymouth Minerals Intersects Further High Grade Potash in Drilling at Banio Potash Project - Plannin
AU$ 0.12-8.00%Trend Power :
Santos(Ngas-Oil)STO.AX
announces expected non-cash impairment
AU$ 7.09-1.12%Trend Power :
Oceana Gold(Au)OGC.AX
RELEASES NEW TECHNICAL REPORT FOR THE HAILE GOLD MINE
AU$ 2.20+0.00%Trend Power :
Western Areas NL(Au-Ni-Pl)WSA.AX
Advance Notice - Full Year Results Conference Call
AU$ 3.86+0.00%Trend Power :
Canadian Zinc(Ag-Au-Cu)CZN.TO
Reports Financial Results for Q2 and Provides Project Updates
CA$ 0.12+4.55%Trend Power :
Stornoway Diamond(Gems-Au-Ur)SWY.TO
Second Quarter Results
CA$ 0.02+100.00%Trend Power :
McEwen Mining(Cu-Le-Zn)MUX
TO ACQUIRE BLACK FOX FROM PRIMERO=C2=A0
US$ 5.55-1.60%Trend Power :
Rentech(Coal-Ngas)RTK
Rentech Announces Results for Second Quarter 2017
US$ 0.20-12.28%Trend Power :
KEFIKEFI.L
Reduced Funding Requirement
GBX 0.72-0.96%Trend Power :
Lupaka Gold Corp.LPK.V
Lupaka Gold Receives First Tranche Under Amended Invicta Financing Agreement
CA$ 0.08+0.00%Trend Power :
Imperial(Ag-Au-Cu)III.TO
Closes Bridge Loan Financing
CA$ 1.94-3.00%Trend Power :
Guyana Goldfields(Cu-Zn-Pa)GUY.TO
Reports Second Quarter 2017 Results and Maintains Production Guidance
CA$ 1.84+0.00%Trend Power :
Lundin Mining(Ag-Au-Cu)LUN.TO
d Share Capital and Voting Rights for Lundin Mining
CA$ 8.36-0.12%Trend Power :
Canarc Res.(Au)CCM.TO
Canarc Reports High Grade Gold in Surface Rock Samples at Fondaway Canyon, Nevada
CA$ 0.18+0.00%Trend Power :
Havilah(Cu-Le-Zn)HAV.AX
Q A April 2017 Quarterly Report
AU$ 0.32+6.67%Trend Power :
Uranium Res.(Ur)URRE
Commences Lithium Exploration Drilling at the Columbus Basin Project
US$ 6.80-2.86%Trend Power :
Platinum Group Metals(Au-Cu-Gems)PTM.TO
Platinum Group Metals Ltd. Operational and Strategic Process ...
CA$ 2.53+2.43%Trend Power :
Devon Energy(Ngas-Oil)DVN
Announces $340 Million of Non-Core Asset Sales
US$ 63.50-1.17%Trend Power :
Precision Drilling(Oil)PD-UN.TO
Announces 2017Second Quarter Financial Results
CA$ 8.66-0.35%Trend Power :
Terramin(Ag-Au-Cu)TZN.AX
2nd Quarter Report
AU$ 0.03+0.00%Trend Power :